ABIO Financial Statements (ABIO) |
|||||||
Артген биотех (ИСКЧ)smart-lab.ru | % | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | |
---|---|---|---|---|---|---|---|
Report date | 03.04.2023 | 02.05.2023 | 01.08.2023 | 30.10.2023 | 01.04.2024 | ||
Currency | RUB | RUB | RUB | RUB | RUB | ||
Financial report URL | |||||||
Revenue, bln rub | ? | 0.000 | 0.015 | 0.018 | 0.012 | 0.029 | |
Net profit, bln rub | ? | 0.083 | 0.008 | 0.022 | 0.033 | 0.182 | |
Dividend payout, bln rub | 0.085 | 0.111 | |||||
Dividend, rub/share | ? | 1 | 1.2 | ||||
Ordinary share dividend yield, % | 1.6% | 0.0% | 0.0% | 0.0% | 1.2% | ||
Dividend payout ratio, % | 102% | 0% | 0% | 0% | 61% | ||
Cost of production, bln rub | 0.015 | 0.013 | 0.011 | 0.014 | 0.018 | ||
Assets, bln rub | 3.72 | 3.81 | 5.32 | 6.25 | 6.05 | ||
Net Assets, bln rub | ? | 3.07 | 3.14 | 4.60 | 5.63 | 5.45 | |
Debt, bln rub | 0.522 | 0.540 | 0.509 | 0.520 | 0.483 | ||
Cash, bln rub | 0.035 | 0.062 | 0.139 | 0.044 | 0.132 | ||
Net debt, bln rub | 0.49 | 0.48 | 0.37 | 0.48 | 0.35 | ||
Ordinary share price, rub | 62.1 | 116.3 | 104.0 | 114.4 | 102.0 | ||
Number of ordinary shares, mln | 92.6 | 92.6 | 92.6 | 92.6 | 92.6 | ||
Market cap, bln rub | 5.75 | 10.8 | 9.64 | 10.6 | 9.45 | ||
EV, bln rub | ? | 6.24 | 11.2 | 10.0 | 11.1 | 9.80 | |
Book value, bln rub | 3.07 | 3.14 | 4.60 | 5.63 | 5.45 | ||
EPS, rub | ? | 0.90 | 0.09 | 0.24 | 0.36 | 1.96 | |
FCF/share, rub | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
BV/share, rub | 33.1 | 33.9 | 49.7 | 60.8 | 58.8 | ||
EBITDA margin, % | ? | 0.0% | 0.0% | 0.0% | 0.0% | ||
Net margin, % | ? | 53.3% | 122.2% | 275.0% | 627.6% | ||
FCF yield, % | ? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
ROE, % | ? | 6.8% | 4.5% | 3.0% | 2.6% | 4.5% | |
ROA, % | ? | 5.6% | 3.7% | 2.6% | 2.3% | 4.0% | |
P/E | ? | 27.6 | 76.4 | 69.3 | 72.6 | 38.6 | |
P/S | ? | 66.1 | 149.6 | 125.2 | 235.5 | 127.7 | |
P/BV | ? | 1.87 | 3.43 | 2.09 | 1.88 | 1.73 | |
CAPEX/Revenue, % | 0% | 0% | 0% | 0% | |||
ABIO shareholders |